Frank Wiesmann

Aberrant methylation of the Wnt antagonist SFRP1 in breast cancer is associated with unfavourable prognosis

Jürgen Veeck, Dieter Niederacher, Han‐Xiang An et al. · Oncogene · 2006 · 254 citations

Tumor Biology, Aberrant Methylation, Breast Oncology +10

Frequent loss of SFRP1 expression in multiple human solid tumours: association with aberrant promoter methylation in renal cell carcinoma

Edgar Dahl, Frank Wiesmann, Matthias Woenckhaus et al. · Oncogene · 2007 · 136 citations

Tumor Biology, Urology, Genitourinary Cancer +12

Decreased expression of angiogenesis antagonist EFEMP1 in sporadic breast cancer is caused by aberrant promoter methylation and points to an impact of EFEMP1 as molecular biomarker

Ariane Sadr‐Nabavi, Juliane Ramser, J. Naehrig et al. · International Journal of Cancer · 2008 · 86 citations · Full text

Breast Oncology, Medicine, Tumor Growth +14

Nuclear detection of Y-boxprotein-1 (YB-1) closely associates with progesterone receptor negativity and is a strong adverse survival factor in human breast cancer

Edgar Dahl, Abdelaziz En‐Nia, Frank Wiesmann et al. · BMC Cancer · 2009 · 63 citations · Full text

The Molecular Structure and Hydrogen Bond Geometry in Liquid Formamide: Electron, Neutron, and X-Ray Diffraction Studies

E. Kálmán, I. Serke, G. Pálinkás et al. · Zeitschrift für Naturforschung A · 1983 · 62 citations · Full text

Crystal Structure, Engineering, Physicochemical Analysis +12